In this study free kappa light chains in cerebrospinal fluid (CSF) were determined both by an affinity mediated capillary blotting technique after isoelectric fccusing (IEF) in agarose gel and by a quantitative enzyme linked immunosorbent assay (ELISA).
Introduction
Several diseases of the nervous system are associated with immunological abnormalities in cerebrospinal fluid (CSF). Selective increase in the CSF IgG level has been observed consistently in MS and it has become an important laboratory test for confirmation of the diagnosis (Poser et al., 1983) . A selective CSF IgG increase can be established by using the IgG Index (Link and Tibbling, 1977) , formulas for intrathecal produced IgG (Reiber and Felgenhauer, 1987; Ghman et a:., 1992) or by detection of CSF restricted oligoclonal IgG bands (Walker et al., 1983; Luxton et al., 1990) .
The IgG finding in MS is nonspecific, as also patients with central nervous system (CNS) infections or inflammatory diseases have regularly elevated CSF IgG levels. Besides IgG, also selective increase of free kappa and lambda light chains (free kappa, free lambda) in CSF has been found in MS and other neuro-immunological disorders (Fagnart et al., 1988; Rudick et al., 1986; Gallo et al., 1989; Decarli et al., 1987) . CSF oligoclonal free kappa bands in MS have been observed with about the same frequency as that for CSF oligoclonal IgG bands (Sindic and Laterre, 1991a) . Free light chain determination in CSF also has relevance for the diagnostics of patients with early MS (Lolli et al., 1991) and the presence of CSF free light chains correlates significantly with recent demyelinating activity in MS (Vakaet and Thompson, 1985; Bracco et al., 1987) . From these studies it is clear that intrathecally produced CSF IgG is mostly accompanied by intrathecally produced CSF free light chains and free light chain detection is a complementary, although optional, test to establish a laboratory-supported diagnosis (Sindic and Laterre, 1991b) . However, in all publications the detection limit for free light chain determination is too high to measure CSF levels in 'normal' patients. Furthermore, the coincidence of free light chain levels with oligoclonal free light chains in CSF and the relation between IgG-and free light chain findings in CSF are not systematically investigated.
Therefore, we developed a sensitive ELISA test for
